Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by BayStreetWildon May 14, 2023 11:53pm
277 Views
Post# 35447693

MM, Executive compensation

MM, Executive compensation

Shouldn't give you fear, uncertainty and doubt.

The company brought in 500k of revenue last month but paid the CEO $901k in total comp last year + expenses. Totally reasonable and in line.

You should be happy to pay for your shares and for management to get a full suite of 7 million RSUs DSUs and PSUs + options last year while you continue to pay their salaries (or are they paying yours?- I digress).  


I also thought it was super cute that the Performance Share Units didn't even factor in this year because none of the old targets were hit so they just skipped all that jazz and went for the guaranteed options + restricted share units. The kicker is that they didn't even wait for the old ones to expire. How much would a fund need to pay to get 4.5 million shares? If you tally all the management incentives up since last year... close to 11.5 million shares. (That's not even including the board or consultants and all of the options).

seems like a lot for a company with a sub 100M market cap.

<< Previous
Bullboard Posts
Next >>